Cardio Diagnostics
Chicago, US · Founded 2020 · Delaware corporation
Find your way into Cardio Diagnostics
Sign up to see every warm intro you have to Cardio Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardio Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Cardio Diagnostics was founded in 2020 by Meeshanthini Dogan and Robert Philibert.
MD
Meeshanthini DoganCo-founder
RP
Robert PhilibertCo-founder · Chief Medical OfficerRobert Philibert is executive officer and director of Cardio Diagnostics, which develops epigenetic-based diagnostic technologies for cardiovascular disease assessment from blood or saliva samples. He is also involved with Behavioral Diagnostics, which offers quantitative epigenetic methods to detect smoking and drinking status.
EL
Elisa LuqmanNamed on SEC filing
WH
Warren HosseinionNamed on SEC filing
WH
Warren HosseinionnNamed on SEC filing
JI
James IntraterNamed on SEC filing
SL
Stanley LauNamed on SEC filing
PB
Paul BurtonNamed on SEC filing
OL
Oded LevyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$14.2M disclosed across 3 rounds · 2021–2024
▶$1MraisedFeb 2024 · 7 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Warren HosseinionnDirector
- James IntraterDirector
- Stanley LauDirector
- Paul BurtonDirector
- Oded LevyDirector
- Elisa LuqmanExecutive Officer
- Robert PhilibertExecutive Officer, Director
- Meeshanthini DoganExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $50K
- Sales commissions
- $100K
- Placement agents
- Altitude Capital Group LLC
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6.5MraisedOct 2022 · 47 investors · BiotechnologyRule 506(b)
▶$6.5MraisedOct 2022 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elisa LuqmanExecutive Officer
- Meeshanthini DoganExecutive Officer, Director
- Robert PhilibertExecutive Officer, Director
- Warren HosseinionDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Minimum investment
- $50K
- Placement agents
- Emerson Equity LLC
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6.7MraisedMay 2022 · 27 investors · BiotechnologyRule 506(b)
▶$6.7MraisedMay 2022 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert PhilibertExecutive Officer, Director
- Elisa LuqmanExecutive Officer
- Warren HosseinionDirector
- Meeshanthini DoganExecutive Officer, Director
- Amount sold
- $6.7M
- Minimum investment
- $25K
- Proceeds to insiders
- $6.7M
- Placement agents
- Emerson Equity LLC
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Cardio Diagnostics?
- Cardio Diagnostics was founded by Meeshanthini Dogan, Robert Philibert in 2020.
- How much funding has Cardio Diagnostics raised?
- Cardio Diagnostics has disclosed $14.2M raised across 3 rounds.
- Where is Cardio Diagnostics headquartered?
- Cardio Diagnostics is headquartered in Chicago, US.
